Synta Pharmaceuticals | Evaluate

January 07, 2016

Wobbles aside, small pharma shares broadly on the up in 2015

October 21, 2015

Synta will have to go back to find the future

August 17, 2015

Unpartnered assets face waiting game

June 03, 2015

Asco Event Analyzer – 2015’s winners and losers

April 22, 2015

Growth of anti-PD1 therapy threatens traditional second line chemo in NSCLC

April 08, 2015

Therapy focus – Potential for progress in mesothelioma is on the horizon

September 22, 2014

Still unpartnered, but now worth a lot more

June 05, 2014

Asco Event Analyzer – 2014’s winners and losers

March 04, 2014

Event – CEO departure leaves a Galaxy of worries for Synta

September 26, 2013

With Infinity’s failure, spotlight falls on Synta

June 06, 2013

Asco Event Analyzer – 2013’s winners and losers

Load More